SCYNEXIS, Inc. (FRA:135A)

Germany · Delayed Price · Currency is EUR

0.5610

+0.0080 (1.45%)

At close: Jan 8, 2026

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	2013 - 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2013 - 2017
Innovative Medicines	140.14M	Log In	Log In	Log In	Log In	Upgrade
Innovative Medicines Growth	2652.72%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	2013 - 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2013 - 2017
United States	140.14M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	2652.72%	Log In	Log In	Log In	Log In	Upgrade
Non-United States	-	Log In	Log In	Log In	Log In	Upgrade
Non-United States Growth	-	Log In	Log In	Log In	Log In	Upgrade